Archives for the 'Member Spotlight' Category
Chembio Diagnostics reported second quarter revenues of $2.72 million, an 8.6% increase over Q2 2007 and higher than any previous quarter. The lion’s share of revenues came from the company’s rapid HIV test; sales were […]
5 August 2008 |
Blog, Member Spotlight, news2 |
Chembio Diagnostics develops, manufactures and markets rapid, point-of-care tests for the detection of HIV 1/ 2, Chagas and Sickle Cell disease as well as other human and veterinary infectious diseases, including tuberculosis (TB). Many of […]
24 July 2008 |
Blog, Member Spotlight, feature2 |
REPEL-CV, SyntheMed’s bioresorbable adhesion barrier film used following cardiac surgery, has received Health Canada approval for use in pediatric patients who undergo open heart procedures. The product will be marketed by Force3 Medicale, a Montreal-based […]
15 July 2008 |
Blog, Member Spotlight, news2 |
Timothy Sullivan, President and CEO of Mystic Pharmaceuticals, has been recognized by the editors of Medical Device & Diagnostic Industry as one of the magazine’s 100 notable people in the device industry.
Sullivan, along with John […]
14 July 2008 |
Member Spotlight |
Chembio Diagnostics has completed a clinical study evaluating the performance of its two FDA approved rapid HIV tests in teens 13-17 years old. The objective of the clinical study, detecting HIV antibodies in this patient […]
7 July 2008 |
Blog, Member Spotlight, news2 |
BioGlue is now available for use in browlift cosmetic and plastic surgery in the EU.
CryoLife, maker of BioGlue, has had its eyes set on the lucrative plastic surgery market since at least 2006 when they […]
11 June 2008 |
Blog, Member Spotlight, news2 |
NovaDel has entered into a collaboration agreement with BioAlliance Pharma SA for the development and commercialization of NovaDel’s ondansetron oral spray (OS) for Europe. Ondansetron is a 5-HT3 antagonist to prevent nausea and vomiting after […]
21 May 2008 |
Member Spotlight |
NovaDel entered into a private placement for up to $4 million, in the form of secured convertible promissory notes with an interest rate of 10% and warrants to purchase shares of the company’s common stock.
NovaDel […]
8 May 2008 |
Member Spotlight |
Bioject Medical develops and markets needle-free injection technology used to administer injectable medications.
Bioject’s technology works by forcing liquid medication at high speed through a tiny orifice (smaller than a human hair) held against the skin. […]
5 May 2008 |
Executive Summary, Blog, Member Spotlight, news2, Video |
Revenues at CryoLife rose 4% to $25.6 million in the first quarter of 2008. Net income was $2.8 million, or $0.10 per share, compared to $1.4 million, or $0.04 per share in Q1 2007.
Tissue processing […]
1 May 2008 |
Blog, Member Spotlight, news2 |
